General Directions: Shake well. Aseptically administer 1 mL subcutaneously.
Primary Vaccination: Healthy cats 9 weeks of age or older should receive 2 doses administered 3–4 weeks apart.
Revaccination: Historically, this product recommended annual revaccination. The need for annual booster vaccinations has not been established for this product; consultation with a veterinarian is recommended.
Cotter SM, Hardy WD Jr, Essex M. Association of feline leukemia virus with lymphosarcoma and other disorders in the cat. J Am Vet Med Assoc. 1975;166(5):449-454.
Store at 2°–8°C. Prolonged exposure to higher temperatures may adversely affect potency. Do not freeze.
Use entire contents when first opened.
Sterilized syringes and needles should be used to administer this vaccine.
Contains gentamicin as preservative.
This product has not been tested in pregnant animals.
As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy.
Do not mix with other products.
In case of human exposure, contact a physician.
This product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are incubating an infectious disease, are malnourished or parasitized, are stressed due to shipment or environmental conditions, are otherwise immunocompromised, or the vaccine is not administered in accordance with label directions.
Technical inquiries should be directed to Zoetis Inc. Veterinary Services, (888) 963-8471.